The "ORS" Deception
Dr. Sivaranjani Santosh, a pediatrician based in Hyderabad, found herself at the center of a significant public health debate after she began raising awareness
about commercially available drinks labeled "ORS" that deviate substantially from the World Health Organization's recommended Oral Rehydration Solution formula. Her campaign focused on educating the public that these popular beverages often contain high levels of sugar, which can be counterproductive and even harmful, particularly for individuals suffering from dehydration due to conditions like diarrhea. This crucial distinction stems from the fact that the WHO-endorsed ORS is specifically formulated with an optimal balance of glucose and electrolytes to effectively combat dehydration, a life-saving intervention. In contrast, Dr. Santosh highlighted that many consumer-oriented hydration drinks, despite their branding, often prioritize taste and sweetness over medical efficacy, potentially exacerbating the very conditions they aim to treat. Her efforts aimed to ensure that people, especially parents, understood this critical difference to make informed choices for their health.
Legal Notice & Corporate Response
Following Dr. Sivaranjani Santosh's public awareness campaign, she received a legal notice from JTNL Consumer Health (India) Private Limited, a company associated with Kenvue Inc. The notice alleged that Dr. Santosh was engaged in maligning the names of their products, ORSL and ERZL, for her own "commercial benefits" and to boost her social media following. This aggressive legal action was perceived by many as an attempt to silence a health professional advocating for accurate information. Dr. Santosh, however, stood firm, asserting that her stance was well-founded and supported by regulatory bodies like the FSSAI. She publicly expressed her disbelief and resolve, questioning the legitimacy of the notice and reiterating her commitment to patient welfare over corporate interests. The doctor suggested that the company's motive was to clear out existing stock, estimated at ₹180 crore, of their high-sugar formulation, further underscoring her concerns about consumer safety and corporate accountability.
Beyond the Label
The core of Dr. Santosh's argument lies in the stark contrast between the medical definition of Oral Rehydration Solution (ORS) and the composition of many popular hydration drinks. While products like ORSL and ERZL are marketed for hydration, especially during illness and for daily fluid replenishment, they fall short of the stringent WHO standards. Dr. Santosh pointed out that these drinks are essentially "repair solutions" with excessive sugar content and inadequate ratios of salt and electrolytes, undermining the efficacy of a genuine ORS. She explained that during diarrheal episodes, high-sugar drinks can worsen the condition, contrary to the intended effect of rehydration. Furthermore, she noted that while disclaimers exist on packaging, such as advising against use during diarrhea, these are often printed in minuscule fonts, making them easily overlooked. The doctor also highlighted a potential conflict of interest, suggesting that pharmacists might favor selling these more expensive products due to higher profit margins, thereby influencing consumer choices away from standard, medically recommended ORS.
A History of Advocacy
Dr. Sivaranjani Santosh's commitment to promoting correct hydration practices predates the recent legal notice. Back in 2022, she initiated a Public Interest Litigation (PIL) in the Telangana High Court. Her petition aimed to compel manufacturers to cease using the abbreviation "ORS" in product names like ORSL, thereby preventing consumer confusion. In response to such legal pressures, some companies began employing marketing tactics like promoting the idea of "silent dehydration," a term not recognized in established medical literature, to position their products. Dr. Santosh documented instances where children experienced life-threatening dehydration despite being given drinks marketed as ORS. Her research and advocacy underscore the critical need for transparency and accurate labeling to ensure that patients receive the life-saving benefits of genuine Oral Rehydration Salts, as recommended by global health authorities like the WHO and UNICEF since 2003.
